ID   DHC24_HUMAN             Reviewed;         516 AA.
AC   Q15392; B7Z817; D3DQ51; Q9HBA8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 2.
DT   18-JUN-2025, entry version 213.
DE   RecName: Full=Delta(24)-sterol reductase;
DE            EC=1.3.1.72 {ECO:0000269|PubMed:11519011, ECO:0000269|PubMed:21671375};
DE   AltName: Full=24-dehydrocholesterol reductase;
DE   AltName: Full=3-beta-hydroxysterol Delta-24-reductase;
DE   AltName: Full=Diminuto/dwarf1 homolog;
DE   AltName: Full=Seladin-1 {ECO:0000303|PubMed:11007892};
DE   Flags: Precursor;
GN   Name=DHCR24; Synonyms=KIAA0018;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=11007892; DOI=10.1523/jneurosci.20-19-07345.2000;
RA   Greeve I., Hermans-Borgmeyer I., Brellinger C., Kasper D., Gomez-Isla T.,
RA   Behl C., Levkau B., Nitsch R.M.;
RT   "The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to
RT   Alzheimer's disease-associated neurodegeneration and oxidative stress.";
RL   J. Neurosci. 20:7345-7352(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, TISSUE SPECIFICITY, VARIANTS
RP   DESMOS LYS-191; THR-294; ASN-306 AND SER-471, CATALYTIC ACTIVITY, AND
RP   CHARACTERIZATION OF VARIANTS DESMOS LYS-191; THR-294; ASN-306 AND SER-471.
RX   PubMed=11519011; DOI=10.1086/323473;
RA   Waterham H.R., Koster J., Romeijn G.J., Hennekam R.C.M., Vreken P.,
RA   Andersson H.C., FitzPatrick D.R., Kelley R.I., Wanders R.J.A.;
RT   "Mutations in the 3beta-hydroxysterol delta24-reductase gene cause
RT   desmosterolosis, an autosomal recessive disorder of cholesterol
RT   biosynthesis.";
RL   Am. J. Hum. Genet. 69:685-694(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [4]
RP   SEQUENCE REVISION TO C-TERMINUS.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   VARIANTS DESMOS HIS-94 AND LYS-480, CHARACTERIZATION OF VARIANTS DESMOS
RP   HIS-94 AND LYS-480, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=21671375; DOI=10.1002/ajmg.a.34040;
RA   Schaaf C.P., Koster J., Katsonis P., Kratz L., Shchelochkov O.A.,
RA   Scaglia F., Kelley R.I., Lichtarge O., Waterham H.R., Shinawi M.;
RT   "Desmosterolosis-phenotypic and molecular characterization of a third case
RT   and review of the literature.";
RL   Am. J. Med. Genet. A 155A:1597-1604(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=22178193; DOI=10.1016/j.bbalip.2011.11.009;
RA   Zerenturk E.J., Kristiana I., Gill S., Brown A.J.;
RT   "The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol
RT   synthesis at DHCR24 (Seladin-1).";
RL   Biochim. Biophys. Acta 1821:1269-1277(2012).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=22010141; DOI=10.1530/jme-11-0132;
RA   Lu X., Li Y., Liu J., Cao X., Wang X., Wang D., Seo H., Gao B.;
RT   "The membrane topological analysis of 3 {beta}-hydroxysteroid-delta24
RT   reductase (DHCR24) on endoplasmic reticulum.";
RL   J. Mol. Endocrinol. 48:1-9(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH DHCR7.
RX   PubMed=25637936; DOI=10.1194/jlr.m056986;
RA   Luu W., Hart-Smith G., Sharpe L.J., Brown A.J.;
RT   "The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact
RT   physically and functionally.";
RL   J. Lipid Res. 56:888-897(2015).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes the reduction of the delta-24 double bond of sterol
CC       intermediates during cholesterol biosynthesis (PubMed:11519011,
CC       PubMed:21671375, PubMed:22178193, PubMed:25637936). In addition to its
CC       cholesterol-synthesizing activity, can protect cells from oxidative
CC       stress by reducing caspase 3 activity during apoptosis induced by
CC       oxidative stress (PubMed:11007892, PubMed:22010141). Also protects
CC       against amyloid-beta peptide-induced apoptosis (PubMed:11007892).
CC       {ECO:0000269|PubMed:11007892, ECO:0000269|PubMed:11519011,
CC       ECO:0000269|PubMed:21671375, ECO:0000269|PubMed:22010141,
CC       ECO:0000269|PubMed:22178193, ECO:0000269|PubMed:25637936}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cholesterol + NADP(+) = desmosterol + NADPH + H(+);
CC         Xref=Rhea:RHEA:36391, ChEBI:CHEBI:15378, ChEBI:CHEBI:16113,
CC         ChEBI:CHEBI:17737, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.72;
CC         Evidence={ECO:0000269|PubMed:11519011, ECO:0000269|PubMed:21671375,
CC         ECO:0000269|PubMed:25637936};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:36393;
CC         Evidence={ECO:0000305|PubMed:11519011, ECO:0000305|PubMed:21671375};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=lanosterol + NADPH + H(+) = 24,25-dihydrolanosterol + NADP(+);
CC         Xref=Rhea:RHEA:33919, ChEBI:CHEBI:15378, ChEBI:CHEBI:16521,
CC         ChEBI:CHEBI:28113, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000269|PubMed:22178193};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33920;
CC         Evidence={ECO:0000269|PubMed:22178193};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5alpha-cholest-8-en-3beta-ol + NADP(+) = zymosterol + NADPH +
CC         H(+); Xref=Rhea:RHEA:36399, ChEBI:CHEBI:15378, ChEBI:CHEBI:16608,
CC         ChEBI:CHEBI:18252, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.72;
CC         Evidence={ECO:0000250|UniProtKB:Q8VCH6};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:36401;
CC         Evidence={ECO:0000250|UniProtKB:Q8VCH6};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- PATHWAY: Steroid biosynthesis; cholesterol biosynthesis.
CC       {ECO:0000269|PubMed:11519011, ECO:0000269|PubMed:21671375}.
CC   -!- SUBUNIT: Interacts with DHCR7; this interaction regulates DHCR7
CC       activity. {ECO:0000269|PubMed:25637936}.
CC   -!- INTERACTION:
CC       Q15392; O00264: PGRMC1; NbExp=2; IntAct=EBI-5457558, EBI-1045534;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11007892, ECO:0000269|PubMed:22010141}; Single-pass
CC       membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:11007892}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15392-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15392-2; Sequence=VSP_056479;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and adrenal gland with
CC       moderate expression in liver, lung, spleen, prostate and spinal cord.
CC       Low expression in heart, uterus and prostate. Undetectable in blood
CC       cells. In the brain, strongly expressed in cortical regions, substantia
CC       nigra, caudate nucleus, hippocampus, medulla oblongata and pons. In
CC       brains affected by Alzheimer disease, expression in the inferior
CC       temporal lobe is substantially lower than in the frontal cortex.
CC       {ECO:0000269|PubMed:11007892, ECO:0000269|PubMed:11519011}.
CC   -!- DISEASE: Desmosterolosis (DESMOS) [MIM:602398]: Rare autosomal
CC       recessive disorder characterized by multiple congenital anomalies and
CC       elevated levels of the cholesterol precursor desmosterol in plasma,
CC       tissue, and cultured cells. {ECO:0000269|PubMed:11519011,
CC       ECO:0000269|PubMed:21671375}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the FAD-binding oxidoreductase/transferase type
CC       4 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA02806.3; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF261758; AAG17288.1; -; mRNA.
DR   EMBL; AF398342; AAL15644.1; -; Genomic_DNA.
DR   EMBL; AF398336; AAL15644.1; JOINED; Genomic_DNA.
DR   EMBL; AF398337; AAL15644.1; JOINED; Genomic_DNA.
DR   EMBL; AF398338; AAL15644.1; JOINED; Genomic_DNA.
DR   EMBL; AF398339; AAL15644.1; JOINED; Genomic_DNA.
DR   EMBL; AF398340; AAL15644.1; JOINED; Genomic_DNA.
DR   EMBL; AF398341; AAL15644.1; JOINED; Genomic_DNA.
DR   EMBL; D13643; BAA02806.3; ALT_INIT; mRNA.
DR   EMBL; AK302774; BAH13803.1; -; mRNA.
DR   EMBL; AC096536; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06663.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06664.1; -; Genomic_DNA.
DR   EMBL; BC004375; AAH04375.1; -; mRNA.
DR   EMBL; BC011669; AAH11669.1; -; mRNA.
DR   CCDS; CCDS600.1; -. [Q15392-1]
DR   RefSeq; NP_055577.1; NM_014762.4. [Q15392-1]
DR   AlphaFoldDB; Q15392; -.
DR   BioGRID; 108064; 186.
DR   CORUM; Q15392; -.
DR   FunCoup; Q15392; 1145.
DR   IntAct; Q15392; 112.
DR   MINT; Q15392; -.
DR   STRING; 9606.ENSP00000360316; -.
DR   BindingDB; Q15392; -.
DR   ChEMBL; CHEMBL2331059; -.
DR   DrugCentral; Q15392; -.
DR   SwissLipids; SLP:000001223; -.
DR   GlyGen; Q15392; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q15392; -.
DR   MetOSite; Q15392; -.
DR   PhosphoSitePlus; Q15392; -.
DR   SwissPalm; Q15392; -.
DR   BioMuta; DHCR24; -.
DR   DMDM; 20141421; -.
DR   jPOST; Q15392; -.
DR   MassIVE; Q15392; -.
DR   PaxDb; 9606-ENSP00000360316; -.
DR   PeptideAtlas; Q15392; -.
DR   ProteomicsDB; 60562; -. [Q15392-1]
DR   ProteomicsDB; 6916; -.
DR   Pumba; Q15392; -.
DR   Antibodypedia; 33226; 238 antibodies from 30 providers.
DR   DNASU; 1718; -.
DR   Ensembl; ENST00000371269.9; ENSP00000360316.3; ENSG00000116133.13. [Q15392-1]
DR   Ensembl; ENST00000436604.2; ENSP00000416585.2; ENSG00000116133.13. [Q15392-1]
DR   GeneID; 1718; -.
DR   KEGG; hsa:1718; -.
DR   MANE-Select; ENST00000371269.9; ENSP00000360316.3; NM_014762.4; NP_055577.1.
DR   UCSC; uc001cyc.2; human. [Q15392-1]
DR   AGR; HGNC:2859; -.
DR   CTD; 1718; -.
DR   DisGeNET; 1718; -.
DR   GeneCards; DHCR24; -.
DR   HGNC; HGNC:2859; DHCR24.
DR   HPA; ENSG00000116133; Tissue enhanced (adrenal gland, liver).
DR   MalaCards; DHCR24; -.
DR   MIM; 602398; phenotype.
DR   MIM; 606418; gene.
DR   neXtProt; NX_Q15392; -.
DR   OpenTargets; ENSG00000116133; -.
DR   Orphanet; 35107; Desmosterolosis.
DR   PharmGKB; PA27320; -.
DR   VEuPathDB; HostDB:ENSG00000116133; -.
DR   eggNOG; KOG1262; Eukaryota.
DR   GeneTree; ENSGT00390000008338; -.
DR   InParanoid; Q15392; -.
DR   OrthoDB; 415825at2759; -.
DR   PAN-GO; Q15392; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q15392; -.
DR   TreeFam; TF313170; -.
DR   BRENDA; 1.3.1.72; 2681.
DR   PathwayCommons; Q15392; -.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-6807047; Cholesterol biosynthesis via desmosterol.
DR   Reactome; R-HSA-6807062; Cholesterol biosynthesis via lathosterol.
DR   SignaLink; Q15392; -.
DR   SIGNOR; Q15392; -.
DR   UniPathway; UPA00063; -.
DR   BioGRID-ORCS; 1718; 22 hits in 1166 CRISPR screens.
DR   ChiTaRS; DHCR24; human.
DR   GeneWiki; 24-dehydrocholesterol_reductase; -.
DR   GenomeRNAi; 1718; -.
DR   Pharos; Q15392; Tchem.
DR   PRO; PR:Q15392; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q15392; protein.
DR   Bgee; ENSG00000116133; Expressed in adrenal tissue and 197 other cell types or tissues.
DR   ExpressionAtlas; Q15392; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000246; F:Delta24(24-1) sterol reductase activity; IMP:UniProtKB.
DR   GO; GO:0050614; F:Delta24-sterol reductase activity; EXP:Reactome.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IDA:MGI.
DR   GO; GO:0042605; F:peptide antigen binding; IPI:UniProtKB.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IEA:Ensembl.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IMP:MGI.
DR   GO; GO:0033489; P:cholesterol biosynthetic process via desmosterol; IMP:UniProtKB.
DR   GO; GO:0033490; P:cholesterol biosynthetic process via lathosterol; TAS:Reactome.
DR   GO; GO:0030539; P:male genitalia development; IEA:Ensembl.
DR   GO; GO:0061024; P:membrane organization; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0031639; P:plasminogen activation; IEA:Ensembl.
DR   GO; GO:0008104; P:protein localization; IEA:Ensembl.
DR   GO; GO:0007265; P:Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:0043588; P:skin development; ISS:UniProtKB.
DR   GO; GO:0008202; P:steroid metabolic process; IBA:GO_Central.
DR   GO; GO:0009888; P:tissue development; IMP:UniProtKB.
DR   FunFam; 3.30.465.10:FF:000032; Delta(24)-sterol reductase; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   InterPro; IPR040165; Diminuto-like.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR006094; Oxid_FAD_bind_N.
DR   PANTHER; PTHR10801; 24-DEHYDROCHOLESTEROL REDUCTASE; 1.
DR   PANTHER; PTHR10801:SF0; DELTA(24)-STEROL REDUCTASE; 1.
DR   Pfam; PF01565; FAD_binding_4; 1.
DR   SUPFAM; SSF56176; FAD-binding/transporter-associated domain-like; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cholesterol biosynthesis; Cholesterol metabolism;
KW   Disease variant; Endoplasmic reticulum; FAD; Flavoprotein; Golgi apparatus;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; NADP; Oxidoreductase;
KW   Proteomics identification; Reference proteome; Signal;
KW   Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis;
KW   Sterol metabolism; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..516
FT                   /note="Delta(24)-sterol reductase"
FT                   /id="PRO_0000007230"
FT   TOPO_DOM        23..31
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000269|PubMed:22010141"
FT   TRANSMEM        32..52
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        53..516
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:22010141"
FT   DOMAIN          58..234
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   BINDING         163..175
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000255"
FT   SITE            122..123
FT                   /note="Cleavage; by caspase"
FT                   /evidence="ECO:0000255"
FT   SITE            383..384
FT                   /note="Cleavage; by caspase"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..76
FT                   /note="MEPAVSLAVCALLFLLWVRLKGLEFVLIHQRWVFVCLFLLPLSLIFDIYYYV
FT                   RAWVVFKLSSAPRLHEQRVRDIQK -> MGAGEQNRQSAHCVQGICGYLEGDEEGEEGE
FT                   VRST (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056479"
FT   VARIANT         94
FT                   /note="R -> H (in DESMOS; decreases production of
FT                   cholesterol from desmosterol; dbSNP:rs387906939)"
FT                   /evidence="ECO:0000269|PubMed:21671375"
FT                   /id="VAR_081889"
FT   VARIANT         191
FT                   /note="E -> K (in DESMOS; decreases production of
FT                   cholesterol from desmosterol; dbSNP:rs119475041)"
FT                   /evidence="ECO:0000269|PubMed:11519011"
FT                   /id="VAR_012732"
FT   VARIANT         294
FT                   /note="N -> T (in DESMOS; decreases production of
FT                   cholesterol from desmosterol; dbSNP:rs281797257)"
FT                   /evidence="ECO:0000269|PubMed:11519011"
FT                   /id="VAR_012733"
FT   VARIANT         306
FT                   /note="K -> N (in DESMOS; decreases production of
FT                   cholesterol from desmosterol; dbSNP:rs281797256)"
FT                   /evidence="ECO:0000269|PubMed:11519011"
FT                   /id="VAR_012734"
FT   VARIANT         471
FT                   /note="Y -> S (in DESMOS; complete loss of ability to
FT                   convert desmosterol to cholesterol; dbSNP:rs28939092)"
FT                   /evidence="ECO:0000269|PubMed:11519011,
FT                   ECO:0000269|PubMed:21671375"
FT                   /id="VAR_012735"
FT   VARIANT         480
FT                   /note="E -> K (in DESMOS; decreases production of
FT                   cholesterol from desmosterol; dbSNP:rs387906940)"
FT                   /evidence="ECO:0000269|PubMed:21671375"
FT                   /id="VAR_081890"
SQ   SEQUENCE   516 AA;  60101 MW;  F9A769446FE19E59 CRC64;
     MEPAVSLAVC ALLFLLWVRL KGLEFVLIHQ RWVFVCLFLL PLSLIFDIYY YVRAWVVFKL
     SSAPRLHEQR VRDIQKQVRE WKEQGSKTFM CTGRPGWLTV SLRVGKYKKT HKNIMINLMD
     ILEVDTKKQI VRVEPLVTMG QVTALLTSIG WTLPVLPELD DLTVGGLIMG TGIESSSHKY
     GLFQHICTAY ELVLADGSFV RCTPSENSDL FYAVPWSCGT LGFLVAAEIR IIPAKKYVKL
     RFEPVRGLEA ICAKFTHESQ RQENHFVEGL LYSLDEAVIM TGVMTDEAEP SKLNSIGNYY
     KPWFFKHVEN YLKTNREGLE YIPLRHYYHR HTRSIFWELQ DIIPFGNNPI FRYLFGWMVP
     PKISLLKLTQ GETLRKLYEQ HHVVQDMLVP MKCLQQALHT FQNDIHVYPI WLCPFILPSQ
     PGLVHPKGNE AELYIDIGAY GEPRVKHFEA RSCMRQLEKF VRSVHGFQML YADCYMNREE
     FWEMFDGSLY HKLREKLGCQ DAFPEVYDKI CKAARH
//
